Republican presumptive nominee Donald Trump has won the New Jersey primary and now-presumptive Democratic nominee Hillary Clinton leads Sen. Bernie Sanders. Worth noting, Mrs. Clinton is underperforming her polling numbers in the Garden State, while Trump, who essentially ran unopposed, is significantly over-performing his polling numbers.
Still, the win is enough for Mrs. Clinton and the media to claim she clinched the Democratic nomination, something she took months longer than anticipated to do against self-proclaimed socialist Vermont Sen. Bernie Sanders. That makes Mrs. Clinton the first female presidential candidate ever to secure a major political party nomination, but also the first male or female to be under federal investigation for political corruption and mishandling classified information.
On Monday, Sen. Sanders pushed back on the notion the race is over, vowing to take the fight to the convention no matter what the outcome Tuesday. That said, PPD projects Mrs. Clinton will likely have enough pledged delegates, that is not counting superdelegates, to clinch the nomination and win on the first ballot at the convention. The state of California will decide whether the former secretary of state will have won enough pledged delegates to flat-out win the nomination by the time Tuesday’s votes are counted.
“There’s nothing to concede,” Sen. Sanders said in reaction. “Secretary Clinton will not get enough pledged delegates to win the nomination and the superdelegates don’t vote until the convention.”
The most damning journalistic sin committed by the media during the era of Russia collusion…
The first ecological study finds mask mandates were not effective at slowing the spread of…
On "What Are the Odds?" Monday, Robert Barnes and Rich Baris note how big tech…
On "What Are the Odds?" Monday, Robert Barnes and Rich Baris discuss why America First…
Personal income fell $1,516.6 billion (7.1%) in February, roughly the consensus forecast, while consumer spending…
Research finds those previously infected by or vaccinated against SARS-CoV-2 are not at risk of…
This website uses cookies.